stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Vivos Therapeutics IncVVOS
$0.09582.24%0.0021
After Hours: 0.10+0.00 +4.38%

Vivos Therapeutics Inc (VVOS)

Vivos Therapeutics Inc Stock (VVOS) Forecast

The Vivos Therapeutics Inc (VVOS) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.17, representing a +1,124% increase from the current price of $0.0958. The highest analyst price target is $1.07, and the lowest is $1.28.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month VVOS Price Target
Average 1.39 (+1,355% Upside)

Is Vivos Therapeutics Inc (VVOS) A Buy Now?

Oscillators
NameValueAction
RSI(14)24.52Buy
STOCH(9,6)9.30Buy
STOCHRSI(14)16.30Buy
MACD(12,26)-0.02Sell
ADX(14)17.44Neutral
William %R-92.79Buy
CCI(14)-100.57Sell
Buy: 4 · Sell: 2 · Neutral: 1Summary: Buy
Moving Averages
PeriodSimpleExponential
MA10
0.11
Sell
0.11
Sell
MA20
0.12
Sell
0.12
Sell
MA50
0.15
Sell
0.17
Sell
MA100
0.27
Sell
0.33
Sell
MA200
0.69
Sell
0.91
Sell
Buy: 0 · Sell: 10 · Neutral: 0Summary: Sell

According to our latest analysis, VVOS could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 12 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on VVOS, as trading bearish markets can be challenging and may result in losses.

  1. RSI (Relative Strength Index): The RSI(14) value of 24.52 indicates that VVOS is oversold. This indicates that VVOS price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
  2. STOCH (Stochastic Oscillator): The STOCH value of 9.30 indicates that VVOS is oversold. This indicates that VVOS price is at or near the lowest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 16.30 indicates that VVOS is oversold. This suggests that VVOS price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of 17.44 suggests that there may be some movement in price, but it lacks strength or conviction.
  5. CCI (Commodity Channel Index): A CCI(14) value of -100.57 indicates that VVOS is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.

Long-term VVOS price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Vivos Therapeutics Inc financial reports and earnings history, Vivos Therapeutics Inc (VVOS) stock could reach $4.84 by 2030, $41.93 by 2040 and $15.61 by 2050. See the projected annual prices until 2050 of the Vivos Therapeutics Inc stock below:

  • Vivos Therapeutics Inc (VVOS) is expected to reach an average price of $1.12 in 2035, with a high prediction of $4.82 and a low estimate of $0.0128. This indicates an +1,067% change from the last recorded price of $0.0958.
  • Vivos Therapeutics Inc (VVOS) stock is projected to chart a bullish course in 2040, with an average price target of $3.24, representing an +3,285% change from its current level. The forecast ranges from a conservative $0.0581 to a sky-high $41.93.
  • Our analysts predict Vivos Therapeutics Inc (VVOS) to change +9,638% by 2045, soaring from $9.43 to an average price of $9.33, potentially reaching $11.60. While $9.43 is the low estimate, the potential upside is significant.
  • Vivos Therapeutics Inc (VVOS) stock is expected to climb by 2050, reaching an average of $13.74, a +14,237% change from its current level. However, a wide range of estimates exists, with high and low targets of $15.61 and $13.33, respectively, highlighting the market's uncertainty.

Vivos Therapeutics Inc Stock (VVOS) Year by Year Forecast

Vivos Therapeutics Inc Stock (VVOS) Price Forecast for 2026

The predicted value for Vivos Therapeutics Inc (VVOS) in 2026 is set at an average of $0.7732. Estimates vary from a peak of $2.69 to a trough of $0.092, indicating an +707.07% surge from the present price of $0.0958.

MonthAverageLowHighChange from today's price
December, 2026$1.01$1.28$1.07+951.61%

Vivos Therapeutics Inc Stock (VVOS) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Vivos Therapeutics Inc (VVOS) is $1.68, with a high forecast of $2.37 and a low forecast of $0.4159. This indicates an +1,652% increase from the last price of $0.0958.

MonthAverageLowHighChange from today's price
January, 2027$1.23$1.50$1.55+1,180%
February, 2027$1.23$1.28$1.09+1,180%
March, 2027$0.6724$0.4159$0.5532+601.89%
April, 2027$1.35$0.9597$0.9516+1,311%
May, 2027$1.46$1.65$1.58+1,422%
June, 2027$1.39$1.58$1.84+1,348%
July, 2027$2.00$1.70$1.87+1,984%
August, 2027$1.88$1.91$2.06+1,866%
September, 2027$2.02$2.10$1.90+2,011%
October, 2027$2.05$2.02$1.94+2,042%
November, 2027$2.45$2.10$2.37+2,459%
December, 2027$2.42$2.38$2.33+2,423%

Vivos Therapeutics Inc Stock (VVOS) Price Forecast for 2028

In 2028, Vivos Therapeutics Inc (VVOS) is projected to reach an average price of $2.25, with a high projection of $2.60 and a low estimate of $1.58. This indicates an +2,253% rise from the last price of $0.0958.

MonthAverageLowHighChange from today's price
January, 2028$2.54$2.48$2.52+2,555%
February, 2028$2.57$2.60$2.60+2,584%
March, 2028$1.61$1.58$1.49+1,583%
April, 2028$2.08$1.81$1.87+2,073%
May, 2028$2.46$2.26$2.41+2,466%
June, 2028$2.42$2.45$2.43+2,430%
July, 2028$2.36$2.37$2.36+2,366%
August, 2028$2.22$2.24$2.26+2,220%
September, 2028$2.08$2.10$2.09+2,068%
October, 2028$2.23$2.25$2.24+2,233%
November, 2028$2.23$2.20$2.21+2,224%
December, 2028$2.24$2.21$2.20+2,235%

Vivos Therapeutics Inc Stock (VVOS) Price Forecast for 2029

The 2029 price forecast for Vivos Therapeutics Inc Stock (VVOS) is $2.96 on average, with a high prediction of $46.50 and a low estimate of $0.00324. This represents an +2,988% increase from the previous price of $0.0958.

MonthAverageLowHighChange from today's price
January, 2029$1.96$2.13$2.66+1,942%
February, 2029$1.73$0.4143$1.99+1,703%
March, 2029$13.05$1.66$46.50+13,520%
April, 2029$5.75$5.42$13.65+5,898%
May, 2029$3.98$2.92$6.98+4,057%
June, 2029$3.71$2.64$4.31+3,776%
July, 2029$2.80$2.08$3.76+2,819%
August, 2029$0.6071$0.3871$1.97+533.69%
September, 2029$0.3579$0.028$0.7426+273.54%
October, 2029$0.3613$0.00324$0.7286+277.17%
November, 2029$0.6321$0.1608$1.15+559.81%
December, 2029$0.5756$0.2029$0.9448+500.81%

Vivos Therapeutics Inc Stock (VVOS) Price Forecast for 2030

Vivos Therapeutics Inc Stock (VVOS) is expected to reach an average price of $1.95 in 2030, with a high forecast of $4.84 and a low forecast of $0.5848. This signifies an +1,937% surge from the last price of $0.0958.

MonthAverageLowHighChange from today's price
January, 2030$1.25$0.6083$1.60+1,201%
February, 2030$0.8571$0.6571$4.26+794.71%
March, 2030$0.9179$0.5848$1.39+858.15%
April, 2030$1.87$0.9506$2.10+1,853%
May, 2030$3.16$1.78$3.93+3,201%
June, 2030$4.30$2.57$4.84+4,392%
July, 2030$1.75$1.64$4.41+1,723%
August, 2030$2.28$1.71$2.46+2,277%
September, 2030$0.8407$0.7207$2.50+777.51%
October, 2030$1.79$0.8533$1.81+1,770%
November, 2030$1.07$0.7968$2.13+1,019%
December, 2030$3.34$0.8849$3.59+3,382%

Similar to VVOS